Literature DB >> 23382015

Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy, and association with survival.

Rafael Alonso-Gonzalez1, Francesco Borgia, Gerhard-Paul Diller, Ryo Inuzuka, Aleksander Kempny, Ana Martinez-Naharro, Oktay Tutarel, Philip Marino, Kerstin Wustmann, Menelaos Charalambides, Margarida Silva, Lorna Swan, Konstantinos Dimopoulos, Michael A Gatzoulis.   

Abstract

BACKGROUND: Restrictive lung defects are associated with higher mortality in patients with acquired chronic heart failure. We investigated the prevalence of abnormal lung function, its relation to severity of underlying cardiac defect, its surgical history, and its impact on outcome across the spectrum of adult congenital heart disease. METHODS AND
RESULTS: A total of 1188 patients with adult congenital heart disease (age, 33.1±13.1 years) undergoing lung function testing between 2000 and 2009 were included. Patients were classified according to the severity of lung dysfunction based on predicted values of forced vital capacity. Lung function was normal in 53% of patients with adult congenital heart disease, mildly impaired in 17%, and moderately to severely impaired in the remainder (30%). Moderate to severe impairment of lung function related to complexity of underlying cardiac defect, enlarged cardiothoracic ratio, previous thoracotomy/ies, body mass index, scoliosis, and diaphragm palsy. Over a median follow-up period of 6.7 years, 106 patients died. Moderate to severe impairment of lung function was an independent predictor of survival in this cohort. Patients with reduced force vital capacity of at least moderate severity had a 1.6-fold increased risk of death compared with patients with normal lung function (P=0.04).
CONCLUSIONS: A reduced forced vital capacity is prevalent in patients with adult congenital heart disease; its severity relates to the complexity of the underlying heart defect, surgical history, and scoliosis. Moderate to severe impairment of lung function is an independent predictor of mortality in contemporary patients with adult congenital heart disease.

Entities:  

Mesh:

Year:  2013        PMID: 23382015     DOI: 10.1161/CIRCULATIONAHA.112.126755

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  Heart failure in adult congenital heart disease.

Authors:  Ada Stefanescu; Doreen DeFaria Yeh; David M Dudzinski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-09

Review 2.  The genetics of congenital heart disease… understanding and improving long-term outcomes in congenital heart disease: a review for the general cardiologist and primary care physician.

Authors:  M Abigail Simmons; Martina Brueckner
Journal:  Curr Opin Pediatr       Date:  2017-10       Impact factor: 2.856

3.  Correlation Between Cardiopulmonary Exercise Test, Spirometry, and Congenital Heart Disease Severity in Pediatric Population.

Authors:  Natalia Morales Mestre; Gregory Reychler; Christophe Goubau; Stéphane Moniotte
Journal:  Pediatr Cardiol       Date:  2019-03-08       Impact factor: 1.655

4.  Abnormal spirometry after the Fontan procedure is common and associated with impaired aerobic capacity.

Authors:  Alexander R Opotowsky; Michael J Landzberg; Michael G Earing; Fred M Wu; John K Triedman; Alicia Casey; Dawn A Ericson; David Systrom; Stephen M Paridon; Jonathan Rhodes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-02       Impact factor: 4.733

5.  A novel NKX2.6 mutation associated with congenital ventricular septal defect.

Authors:  Juan Wang; Jian-Hui Mao; Ke-Ke Ding; Wei-Jun Xu; Xing-Yuan Liu; Xing-Biao Qiu; Ruo-Gu Li; Xin-Kai Qu; Ying-Jia Xu; Ri-Tai Huang; Song Xue; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2014-11-08       Impact factor: 1.655

6.  A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Authors:  Yun Pan; Zha-Gen Wang; Xing-Yuan Liu; Hong Zhao; Ning Zhou; Gui-Fen Zheng; Xing-Biao Qiu; Ruo-Gu Li; Fang Yuan; Hong-Yu Shi; Xu-Min Hou; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2015-04-10       Impact factor: 1.655

7.  Rapid Improvement of Pulmonary Functions in Children After Transcatheter Closure of an Atrial Septal Defect.

Authors:  Serkan F Çelik; Cemşit Karakurt; Nurdan Yıldırım Acar; Elif Çelik
Journal:  Pediatr Cardiol       Date:  2017-10-31       Impact factor: 1.655

8.  Causes of Death in Infants and Children with Congenital Heart Disease.

Authors:  Jason L Williams; Rachel D Torok; Alfred D'Ottavio; Tracy Spears; Karen Chiswell; Nina E Forestieri; Charlie J Sang; Joseph A Paolillo; Michael J Walsh; Timothy M Hoffman; Alex R Kemper; Jennifer S Li
Journal:  Pediatr Cardiol       Date:  2021-04-22       Impact factor: 1.655

Review 9.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

10.  KLF2-mediated disruption of PPAR-γ signaling in lymphatic endothelial cells exposed to chronically increased pulmonary lymph flow.

Authors:  Catherine J Morris; Rebecca J Kameny; Jason Boehme; Wenhui Gong; Youping He; Terry Zhu; Emin Maltepe; Gary W Raff; Jeffrey R Fineman; Sanjeev A Datar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.